spinal cord

Paederosidic acid methyl ester has antinociception, is possibly related to the pathway of NO-cGMP-ATP sensitive K(+) channels.

SRS16-86 is a novel third-generation ferrostatin, is an inhibitor of ferroptosis.

ALX-1393 is a selective GlyT2 inhibitor that effectively reduces neuronal action potential activity in a concentration-dependent manner and inhibits the activity of spontaneous networks by inducing glycinergic tetanic currents in the abdominal horn of the spinal cord. Antiinjurious effects on thermal, mechanical and chemical stimuli in rat models of acute pain.

Chroman 1 is an inhibitor of ROCK2 (IC50: 1 nM).

(R)-3,4-DCPG HCl is a potent and selective mGlu8a receptor agonist that activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord.

Aprikalim (RP 52891) is an adenosine triphosphate potassium channel (KATP) opener that protects against nerve damage in a rabbit model of spinal cord ischemia.Aprikalim inhibits vasoconstriction and inhibits the elevation of [Ca2+]i during myocardial paralysis, and can be used to study cardiovascular disease.

Silperisone HCl (RGH-5002) blocks sodium and calcium channels in cells, decreases excitability and contractility of muscle cells, reduces peripheral tone, and acts as a muscle relaxant and peripheral vasodilator. Silperisone HCl is used to treat recurrent painful myoclonus due to spinal cord injury, abnormal hypertonia due to cerebrovascular disease, dystonia symptoms, cone tension syndrome, multiple sclerosis myospasm and myelitis. silperisone is a sodium channel protein type 2 alpha channel blocker. silperisone is an organosilicon similar to tolperisone, an organosilicon compound with centrally acting muscle relaxant properties.

Tirilazad mesylate (U 74006F) is a non-glucocorticoid, lipid peroxidation inhibitor with antiviral and neuroprotective activities. It confines intracellular intramembranous foci, attenuates spinal cord injuries induced by trauma, stroke, and ischemia/reperfusion injuries, inhibits toxins in dogs, and is used in the study of neurological disorders.

KCL-286 is an orally available and potent retinoic acid receptor beta agonist for the amelioration of spinal cord injury (SCI).

Baclofen (Lioresal) is a synthetic chlorophenyl-butanoic acid derivative used to treat spasms due to spinal cord damage and multiple sclerosis, muscle-relaxing Baclofen acts as a gamma-aminobutyric acid (GABA) agonist specific for GABA-B receptors. It acts at spinal and supraspinal sites, reducing excitatory transmission.

Baclofen hydrochloride (4-amino-3-(4-chlorophenyl)butanoic acid hydron chloride) is a GAMMA-AMINOBUTYRIC ACID derivative that is a specific GABA-B RECEPTORS agonist. It is used in the treatment of MUSCLE SPASTICITY, especially that due to SPINAL CORD INJURIES. Its therapeutic effects result from actions at spinal and supraspinal sites, generally the reduction of excitatory transmission.

BIA 10-2474 is a long-acting reversible inhibitor of fatty acid amide hydrolase (FAAH) that increases levels of the neurotransmitter anandamide in the central nervous system and in peripheral tissues (that is, the rest of the body other than the brain and spinal cord). BIA 10-2474(BIA10-2474) interacts with the human endocannabinoid system. BIA 10-2474(BIA10-2474) was in development for the treatment of a range of different medical conditions from anxiety to Parkinson's disease, also for the treatment of chronic pain of multiple sclerosis, Y, hypertension or the treatment of obesity.

Peptide5 acetate reduces animal swelling, astrogliosis, and neuronal cell death after spinal cord injury. Peptide5 acetate significantly reduces the degree of spinal cord injury (SCI) in a rodent ex vivo model.

Oleoyl proline is a novel class of N-acylamine compounds that can be used for related research in the life sciences.

ALLM (Calpain inhibitor II), a potent calpain and cathepsin protease inhibitor, not only prevents neuronal cell death but also enhances chronic neurological function following spinal cord injury (SCI)[1][2].

Arbaclofen hydrochloride, a Gamma-Aminobutyric Acid derivative, is a specific agonist of GABA-B receptors, it is used to treat spasticity, especially that due to spinal cord damage. It acts at spinal and supraspinal sites, generally reduces excitatory tra

LY-266097, a selective 5-HT2BR antagonist, effectively reduces tactile hypersensitivity and demonstrates potential therapeutic effects in alleviating pain caused by nerve injury. Additionally, it decreases the upregulation of 5-HT2B receptors in the dorsal root ganglia and spinal cord following nerve damage. Research indicates that LY-266097 may play a potential role in the development of neuropathic pain pathways.

Jun6504 is an inhibitor of enterovirus (enterovirus) 2C protein. It exhibits potent broad-spectrum antiviral activity against various strains of EV-D68 (EC50= 250 nM), EV-A71 (EC50= 502.4 nM), and CVB3 (EC50= 1049 nM). In a neonatal mouse model infected with EV-D68, Jun6504 improves paralysis scores and promotes weight gain. It reduces viral titers in the spinal cord and infected quadriceps muscle. Jun6504 is useful for researching antivirals against EV-D68.

Dimephosphon is an anti-inflammatory agent exhibiting both antihistamine and antiserotonin activities. It aids in maintaining spinal cord conduction function and reduces the excitability of motor neurons around lesion areas. Additionally, Dimephosphon directly stimulates lymph vessel movement, enhancing lymph circulation. This compound is useful for studying inflammatory edema, acute spinal cord injuries, and lymphatic circulation disorders.

Methylprednisolone Acetate(Depo-Medrate) has the ability to inhibit oxygen free radicals and can be used to treat acute spinal cord injuries.

Ganglioside GT1b bovine trisodium is a trisialoganglioside that binds to botulinum toxin type A (BTxA), BTxA heavy chain, and tetanus toxin with IC50 values of 11, 0.74, and 7.2 μM, respectively. It acts as a TLR2 agonist in spinal cord microglia, leading to microglial activation, increased expression of pro-inflammatory factors, and heightened pain sensitivity. Additionally, Ganglioside GT1b bovine trisodium reduces the production of IL-6, IL-10, IgG, IgM, and IgA in human peripheral blood mononuclear cells (PBMC). In neuronal cell models, it elevates extracellular glutamate levels. Ganglioside GT1b bovine trisodium is used in the research of immune and neurological disorders.

Glutathione trisulfide (GSSSG) is a potent neuroprotective agent with anti-inflammatory properties. It inhibits lipopolysaccharide (LPS)-induced inflammatory gene expression in retinal pigment epithelial cells through excessive activation of the ERK signaling pathway, independently of the NRF2/HMOX1 pathway. GSSSG is applicable in research on neurodegenerative diseases and ischemic spinal cord injury (SCI).

EED-IN-5 is an orally active, EZH2-selective trisubstituted pyridine EED-H3K27me3 inhibitor and immunomodulator with anti-inflammatory properties. It targets EED with an IC50 of 28.21 nM. In mouse models, oral administration of EED-IN-5 leads to preferential and sustained accumulation in lymph nodes. This compound reduces H3K27me3 levels in dendritic cells and inhibits their migration, consequently decreasing the infiltration of specific dendritic cells, macrophages, and T cells into the spinal cord and brain. EED-IN-5 shows hERG inhibition activity, tests negative in Mini-Ames assays, and does not exhibit significant toxicity with long-term high-dose administration. EED-IN-5 is applicable for multiple sclerosis research.

GPR17 agonist 2 (compound 10) is an agonist for the human GPR17 receptor. By functionally activating its target receptor, GPR17 agonist 2 regulates intracellular cAMP levels. It is useful for research related to multiple sclerosis, cerebral ischemia, traumatic brain injury, and spinal cord injury.